Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Arvee Laboratories (India) Ltd

Chemicals & Petrochemicals | Small Cap

Arvee Laboratories (India) Ltd Health Insights
Health Score : 7.86Health Score : 7.86

Arvee Laboratories demonstrates a mixed financial performance. The company shows strength in solvency and profitability, indicating a solid foundation and efficient operations. Growth metrics are also strong, particularly in revenue and earnings per share. However, efficiency ratios are weak, suggesting challenges in asset utilization. Liquidity is reasonable, providing some financial flexibility. The company maintains a strong interest coverage ratio, but does not distribute dividends. This overview suggests that Arvee Laboratories has robust profitability and growth potential, but needs to improve its operational efficiency to achieve more balanced financial health. While adjusted EPS and book value per share are low, capital expenditures are managed effectively. Overall, the company presents a promising investment opportunity with some operational areas needing attention.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Arvee Laboratories (India) Ltd Health Insights
Health Score : 7.86Health Score : 7.86

Arvee Laboratories demonstrates a mixed financial performance. The company shows strength in solvency and profitability, indicating a solid foundation and efficient operations. Growth metrics are also strong, particularly in revenue and earnings per share. However, efficiency ratios are weak, suggesting challenges in asset utilization. Liquidity is reasonable, providing some financial flexibility. The company maintains a strong interest coverage ratio, but does not distribute dividends. This overview suggests that Arvee Laboratories has robust profitability and growth potential, but needs to improve its operational efficiency to achieve more balanced financial health. While adjusted EPS and book value per share are low, capital expenditures are managed effectively. Overall, the company presents a promising investment opportunity with some operational areas needing attention.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Highly Overvalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Highly Overvalued

P/E RATIO (TTM)

72.92

Highly Overvalued

Industry Median

29.91

Highly Overvalued
Highly Overvalued

Small Cap Median

28.59

Highly Overvalued

P/E RATIO

72.60

P/B RATIO

5.44

Highly Overvalued

Industry Median

2.51

Highly Overvalued
Highly Overvalued

Small Cap Median

2.38

Highly Overvalued

P/S RATIO

5.51

Highly Overvalued

Industry Median

2.22

Highly Overvalued
Highly Overvalued

Small Cap Median

1.92

Highly Overvalued

Others

Highly Undervalued

PEG RATIO

-63.13

Highly Undervalued
Overvalued

EV/EBITDA RATIO

44.31

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹166.98 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 8.00

Arvee Laboratories exhibits strong growth in revenue and earnings per share, indicating a positive trajectory in core business performance. However, the operating profit growth rate and asset growth rate are low, suggesting potential challenges in profitability and asset expansion. The weighted average calculation underscores the recent growth trends and areas needing improvement. The company shows good growth in revenue and has potential for future growth. The company is financially stable.

ExcellentRevenue Growth RateExcellent
PoorOperating Profit Growth RatePoor
ExcellentEarnings Per Share (EPS) GrowthExcellent
PoorAsset Growth RatePoor
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate-14.8852.12-50.5326.82-18.13
Operating Profit Growth Rate-6.4328.35-59.6722.79-11.63
Earnings Per Share (EPS) Growth-4.1260.52-74.6105.2617.95
Asset Growth Rate-5.770.03-0.34-2.5415.11
Net Income Growth Rate-4.160.31-74.51104.7617.67
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 3.60

The financial ratios present a mixed view of Arvee Laboratories' financial health. Capital expenditures are well-managed, but adjusted EPS, cash EPS, and book value per share are low. The company does not distribute dividends. The weighted average calculation emphasizes the need for improvement in key financial metrics. Better financial metrics are required for the company to perform better. There is a need for better financial metrics for the company to perform better.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
GoodCapital Expenditures (CapEx)Good
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)2.253.740.921.862.3
Cash Earnings Per Share (Cash EPS)4.455.642.3233.4
Book Value Per Share21.7625.5126.4628.4230.72
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)2.41.52.61.92.8
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

Arvee Laboratories exhibits excellent profitability, as demonstrated by strong gross profit margin, ROCE, ROE, ROA, operating margin, and net margin. This demonstrates effective cost management and efficient operations. The weighted average calculation confirms these robust profitability metrics. These ratios collectively suggest a solid foundation for sustained financial success. The company is having a very good profitability and financial stability for future success. The company is very efficient and is very stable.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin8.338.494.746.396.28
Return on Capital Employed (ROCE)12.8923.346.839.587.92
Return on Equity (ROE)10.7414.683.616.887.49
Return on Assets (ROA)14.6818.847.629.617.37
Operating Margin14.0811.889.699.3810.12
Net Margin6.376.723.465.598.03
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.67

The efficiency ratios reveal mixed performance in asset utilization. The inventory turnover and days sales in inventory are average, indicating moderate efficiency in inventory management. However, the fixed asset turnover, receivables turnover, receivable days, and capital turnover ratios are weak, suggesting potential inefficiencies in utilizing assets and managing receivables. Better asset management can improve the company's overall financial health. The company needs to work on its efficiency for better results. The company can be seen as an average company in terms of efficiency.

PoorFixed Asset Turnover RatioPoor
AverageInventory Turnover RatioAverage
WeakReceivables Turnover RatioWeak
AverageDays Sales in Inventory RatioAverage
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.914.842.42.521.88
Inventory Turnover Ratio5.6210.95.276.584.3
Receivables Turnover Ratio4.035.033.35.313.34
Days Sales in Inventory Ratio64.9533.4969.2655.4784.88
Receivable Days90.5772.56110.6168.74109.28
Capital Turnover Ratio1.622.111.011.190.9
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

Arvee Laboratories has a strong capacity to cover its interest expenses, as reflected in the interest coverage ratio. However, the equity dividend coverage ratio is low, indicating that the company is not distributing dividends. The weighted average calculation highlights the company's ability to manage its interest obligations effectively. This reflects a conservative approach to shareholder returns. The company is able to cover its interest expenses but it is not distributing dividends.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio10.3216.828.3212.4811.57
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

Arvee Laboratories exhibits excellent solvency, characterized by low debt ratios and a high equity ratio. This indicates a conservative capital structure and a strong financial cushion. The weighted average calculation highlights consistent debt management and reliance on equity financing. These ratios collectively suggest a low risk of financial distress and a stable foundation for future growth. The Company is having a very good solvency position as it shows that the company has a very low risk of financial distress. Low Debt and High Equity is a sign of a good company.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.040.030.030.030.03
Debt to Equity Ratio0.040.030.030.030.03
Equity Ratio0.960.970.970.970.97
Debt To Asset Ratio0.030.030.030.030.03
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 8.38

The company's liquidity position shows strong current and quick ratios, indicating a good ability to meet short-term obligations. The cash ratio is adequate, reflecting a reasonable level of liquid assets. However, the operating cash flow ratio is weak, suggesting potential issues in generating cash from operations. This ratio indicates the company can comfortably cover its short term liabilities with its current assets. This potentially gives the company the ability to invest in growth opportunities. However, the dependence on current assets to maintain liquidity could be improved by increasing cash flow from operations.

ExcellentCurrent RatioExcellent
ExcellentQuick RatioExcellent
GoodCash RatioGood
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.742.542.754.083.07
Quick Ratio1.322.0723.221.97
Cash Ratio0.340.090.220.930.39
Operating Cash Flow Ratio0.050.30.43-0.04-0.01
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 8 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Arvee Laboratories (India) Ltd7.8672.60Highly Overvalued3.192.292.53
2Diamines & Chemicals Ltd7.37-18.93Neutral-14.00-11.05-13.00
3Indian Emulsifiers Ltd7.245.25Neutral26.008.8416.00
4Vital Chemtech Ltd7.2025.50Neutral10.003.741.00
5Ambani Orgochem Ltd5.3976.32Neutral16.001.771.00
6Hindcon Chemicals Ltd5.3131.20Overvalued3.660.633.08
7Alkali Metals Ltd5.12-17.05Neutral7.720.550.56
Management Assessment Summary
OrangeBalanced Management

The management effectiveness of Arvee Laboratories presents a mixed picture, characterized by both strengths and weaknesses. The high promoter holding and sales growth are positive indicators, but concerns arise from inconsistent profitability and low returns on capital. While debt is managed prudently, the overall financial performance requires improvement for sustained investor confidence.

Category Metric Value Assessment
PROS Promoter Holding 73.50% Indicates strong confidence in the company's prospects.
Sales Growth (TTM) 27% Reflects positive momentum in revenue generation.
CONS Return on Capital Employed 10.00% Suggests inefficient utilization of capital.
Net Profit Growth (TTM) 113% Demonstrates significant inconsistency in profitability from -98.73% to 366.67%
AverageFinancial Performance & GrowthAverage
PoorCapital Efficiency & ReturnsPoor
GoodFinancial Health & PrudenceGood
ExcellentShareholding & Ownership StructureExcellent
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Arvee Laboratories faces a moderate risk profile due to segment performance volatility and relatively low returns on capital employed. While the company maintains a high promoter holding, the inconsistent profitability and sales growth present challenges. Additionally, the cash conversion cycle shows variability, indicating potential inefficiencies in working capital management.

WeakSegment performance volatilityWeak
01.

Segment performance volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10167.38Bearish
  3. SMA 20168.73Bearish
  4. SMA 50168.82Bearish
  5. EMA 10167.84Bearish
  6. EMA 20168.35Bearish
  7. EMA 50168.05Bearish
  8. DEMA 10167.16Bearish
  9. DEMA 20167.81Bearish
  10. DEMA 50169.47Bearish
  11. TEMA 10166.96Bullish
  12. TEMA 20167.05Bullish
  13. TEMA 50169.08Bearish
  14. MACD-0.48Bearish
  15. ADX18.14Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI46.98Neutral
  3. CCI-87.35Neutral
  4. ROC 91.25Bullish
  5. ROC 14-2.37Bearish
  6. ROC 25-0.84Bearish
  7. Stoch K21.24Neutral
  8. Stoch D37.43Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper173.13Neutral
  3. BB Middle168.73Neutral
  4. BB Lower164.33Neutral
  5. ATR2.73Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI45.52Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10168.94Bearish
  3. SMA 20169.42Bearish
  4. SMA 50166.23Bullish
  5. EMA 10168.57Bearish
  6. EMA 20168.65Bearish
  7. EMA 50167.08Bullish
  8. DEMA 10168.01Bearish
  9. DEMA 20169.27Bearish
  10. DEMA 50169.35Bearish
  11. TEMA 10167.47Bearish
  12. TEMA 20168.30Bearish
  13. TEMA 50170.40Bearish
  14. MACD0.28Bearish
  15. ADX28.06Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI47.89Neutral
  3. CCI-129.10Oversold
  4. ROC 9-2.37Bearish
  5. ROC 14-1.71Bearish
  6. ROC 25-0.67Bearish
  7. Stoch K45.30Neutral
  8. Stoch D52.67Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper173.32Neutral
  3. BB Middle169.42Neutral
  4. BB Lower165.53Neutral
  5. ATR3.95Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI50.67Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10169.99Bearish
  3. SMA 20167.84Bearish
  4. SMA 50164.42Bullish
  5. EMA 10169.17Bearish
  6. EMA 20167.91Bearish
  7. EMA 50165.45Bullish
  8. DEMA 10170.03Bearish
  9. DEMA 20170.24Bearish
  10. DEMA 50168.50Bearish
  11. TEMA 10169.28Bearish
  12. TEMA 20170.99Bearish
  13. TEMA 50N/AN/A
  14. MACD1.70Bearish
  15. ADX46.71Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI49.92Neutral
  3. CCI8.25Neutral
  4. ROC 9-3.07Bearish
  5. ROC 142.58Bullish
  6. ROC 257.05Bullish
  7. Stoch K39.69Neutral
  8. Stoch D40.34Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper174.83Neutral
  3. BB Middle167.84Neutral
  4. BB Lower160.86Neutral
  5. ATR7.21High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI86.18Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10166.50Bearish
  3. SMA 20163.46Bullish
  4. SMA 50163.66Bullish
  5. SMA 100158.94Bullish
  6. SMA 200168.22Bearish
  7. EMA 10166.52Bearish
  8. EMA 20164.99Bearish
  9. EMA 50163.18Bullish
  10. EMA 100164.07Bullish
  11. EMA 200165.96Bearish
  12. DEMA 10168.50Bearish
  13. DEMA 20167.04Bearish
  14. DEMA 50163.95Bullish
  15. DEMA 100161.22Bullish
  16. DEMA 200164.17Bullish
  17. TEMA 10169.08Bearish
  18. TEMA 20167.91Bearish
  19. TEMA 50167.07Bearish
  20. TEMA 100160.84Bullish
  21. TEMA 200160.82Bullish
  22. MACD1.70Bullish
  23. ADX35.95Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI50.55Neutral
  3. CCI34.88Neutral
  4. ROC 143.00Bullish
  5. ROC 252.91Bullish
  6. Stoch K37.33Neutral
  7. Stoch D40.44Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper172.25Neutral
  3. BB Middle163.46Neutral
  4. BB Lower154.68Neutral
  5. ATR10.86Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI84.84Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20159.51Bullish
  3. SMA 50170.58Bullish
  4. EMA 20164.91Bullish
  5. EMA 50167.16Bullish
  6. DEMA 20162.22Bullish
  7. DEMA 50166.62Bullish
  8. TEMA 20162.30Bullish
  9. TEMA 50162.41Bullish
  10. MACD-1.57Bullish
  11. ADX13.85Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI50.94Neutral
  3. CCI7.68Neutral
  4. ROC 148.06Bullish
  5. ROC 25-41.30Bearish
  6. Stoch K64.27Neutral
  7. Stoch D60.08Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper180.68Neutral
  3. BB Middle159.51Neutral
  4. BB Lower138.33Neutral
  5. ATR22.64High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI83.91Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6165.38Bearish
  3. SMA 12165.20Bullish
  4. SMA 24166.77Bearish
  5. EMA 6161.70Bullish
  6. EMA 12162.85Bullish
  7. EMA 24159.79Bullish
  8. DEMA 6160.41Bullish
  9. DEMA 12162.18Bullish
  10. DEMA 24171.79Bearish
  11. TEMA 6160.74Bullish
  12. TEMA 12158.94Bullish
  13. TEMA 24162.18Bullish
  14. MACD21.95Bearish
  15. ADX64.71Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI53.92Neutral
  3. CCI38.06Neutral
  4. ROC 25-26.35Bearish
  5. ROC 5045.32Bullish
  6. Stoch K24.60Neutral
  7. Stoch D29.58Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper197.60Neutral
  3. BB Middle162.88Neutral
  4. BB Lower128.16Neutral
  5. ATR43.00Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI95.28Overbought